I agree that this site is using cookies. You can find further informations here.
X
Nahass, Ronald
107  results:
Search for persons X
?
1

Health-related quality of life in people receiving opioid a..:

Dalgard, Olav ; Litwin, Alain H. ; Shibolet, Oren...
Journal of Addictive Diseases.  41 (2022)  3 - p. 213-224 , 2022
Link: https://doi.org/10.1080/..
 
?
2

Antiviral activity and safety of the hepatitis B core inhib..:

Yuen, Man-Fung ; Agarwal, Kosh ; Ma, Xiaoli...
Journal of Hepatology.  73 (2020)  - p. S140 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Risk Factors and Outcomes of Hospitalized Patients With Sev..:

Bhatt, Pinki J ; Shiau, Stephanie ; Brunetti, Luigi...
Clinical Infectious Diseases.  72 (2020)  12 - p. e995-e1003 , 2020
Link: https://doi.org/10.1093/..
 
?
4

Antiviral activity and safety of the hepatitis B core inhib..:

Fung, Scott ; Sulkowski, Mark ; Lalezari, Jacob...
Journal of Hepatology.  73 (2020)  - p. S51-S52 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Patient-reported outcomes among people receiving opioid ago..:

Dalgard, Olav ; Litwin, Alain ; Dore, Gregory...
Journal of Hepatology.  73 (2020)  - p. S356 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Efficacy and safety results of the phase 2 JNJ-56136379 JAD..:

Janssen, Harry ; Hou, Jinlin ; Asselah, Tarik...
Journal of Hepatology.  73 (2020)  - p. S129-S130 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Efficacy and Safety of Elbasvir/Grazoprevir in Hepatitis C ..:

Flamm, Steven ; Peng, Cheng-Yuan ; Shibolet, Oren...
Gerontology and Geriatric Medicine.  5 (2019)  - p. 233372141881739 , 2019
Link: https://doi.org/10.1177/..
 
?
8

LBO-06-Interim safety and efficacy results of the ABI-H0731..:

Ma, Xiaoli ; Lalezari, Jacob ; Nguyen, Tuan...
Journal of Hepatology.  70 (2019)  1 - p. e130 , 2019
Link: https://doi.org/10.1016/..
 
?
9

467. Investigation of a Clostridium difficile Infection (CD..:

Parker, Laura ; Parrillo, Sharon ; Nahass, Ronald
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S175-S175 , 2018
Link: https://doi.org/10.1093/..
 
?
10

Mo1387 - Efficacy and Safety of Elbasvir (EBR)/Grazoprevir ..:

Flamm, Steven L. ; Peng, Cheng-Yuan ; Shibolet, Oren...
Gastroenterology.  154 (2018)  6 - p. S-1190 , 2018
Link: https://doi.org/10.1016/..
 
?
11

2203. Risk Factors for Hepatitis C in Western Africa: An Ob..:

Akyar, Eda ; Mora, Nallely ; Luke, Amy...
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S650-S650 , 2018
Link: https://doi.org/10.1093/..
 
?
12

Hepatitis C Virus (HCV) Reinfection and Injection Risk Beha..:

Haber, Barbara ; Gane, Edward ; Dore, Gregory J....
Gastroenterology.  152 (2017)  5 - p. S1058-S1059 , 2017
Link: https://doi.org/10.1016/..
 
?
13

Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C vir..:

Wyles, David ; Wedemeyer, Heiner ; Ben‐Ari, Ziv...
Hepatology.  66 (2017)  6 - p. 1794-1804 , 2017
Link: https://doi.org/10.1002/..
 
?
14

The emergence of NS5B resistance associated substitution S2..:

Gane, Edward J. ; Metivier, Sophie ; Nahass, Ronald...
Hepatology Communications.  1 (2017)  6 - p. 538-549 , 2017
Link: https://doi.org/10.1002/..
 
?
15

Sofosbuvir/Velpatasvir Plus GS-9857 (100 Milligrams) for 6,..:

Nahass, Ronald ; Lawitz, Eric ; Jacobson, Ira M....
Open Forum Infectious Diseases.  3 (2016)  suppl_1 - p. , 2016
Link: https://doi.org/10.1093/..
 
1-15